MedTrace Logo

Furosemide Versus Ethacrynic Acid in Children With Congenital Heart Disease

NCT01628731 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 74

Last updated 2014-07-24

No results posted yet for this study

Summary

This study aims to verify if ethacrynic acid continuous infusion is superior to furosemide continuous infusion in total urine output production during the first 24 post operative hours.

Conditions

  • Fluid Overload

Interventions

DRUG

furosemide

furosemide, intravenous, continuous infusion, 0.2 mg/kg/h for 24 hours

DRUG

ethacrynic acid

ethacrynic acid, intravenous, continuous infusion, 0.2 mg/kg/h for 24 hours

Sponsors & Collaborators

  • Bambino Gesù Hospital and Research Institute

    lead OTHER

Principal Investigators

  • Zaccaria Ricci, MD · Bambino Gesù Hospital RI

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Max Age
10 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2013-07-31
Completion
2013-11-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01628731 on ClinicalTrials.gov